724 organization(s) found
Asher Bio
At Asher Biotherapeutics, we are pioneering a new approach with our cis_targeted immunotherapies. Our immunotherapies selectively activate only the immune cell types that drive the desired therapeutic response. With this innovation, we address an inherent shortcoming of conventional immunotherapies, which indiscriminately act on multiple cell types, resulting in suboptimal efficacy and side effects.
Asian Pediatric Hematology & Oncology Group (APHOG)
The Asian Pediatric Hematology & Oncology Group (APHOG) is a non-political, non-commercial, non-profit organization connecting and helping all pediatric hematology and oncology professionals & patients. in the Asian region. Its goal is to improve the diagnosis and treatment of childhood and AYA cancers.
Asia-Pacific Blood & Marrow Transplant Group (APBMT)
The Asia-Pacific Blood and Marrow Transplantation Group (APBMT) was initiated by transplant physicians from Australia, China, Hong Kong, India, Japan, Republic of Korea, Malaysia and Taiwan in 1990 to share the information regarding hematopoietic stem cell transplantation (HSCT) and promote collaborative basic and clinical studies. They held early APBMT meetings in China and Japan from 1990 to 1994. Since then, the plenary meetings have been held 4 times from 1995 to 2003 and they have been held annually since 2004. As of August 2024, APBMT comprised 23 countries / regions (Australia, Bangladesh, Cambodia, China, Hong Kong, India, Indonesia, Iran, Japan, Korea, Malaysia, Mongolia, Myanmar, Nepal, New Zealand, Pakistan, the Philippines, Singapore, Sri Lanka, Taiwan, Thailand, Uzbekistan, and Vietnam) and are leading a variety of issues regarding HSCT in the Asia-Pacific region.
Asia Pacific Leukemia Consortium (APLC)
The Asia-Pacific Leukemia Consortium (APLC) is a not for profit initiative to improve the management of leukemia and related diseases in the Asia-Pacific (APAC) region. The group aims to address the growing threat of leukemia in APAC region through a collaborative approach to advance disease prevention, patient care, research, clinical trials, and education.
ASNO (Asian Society for Neuro-Oncology)
ASNO (Asian Society for Neuro-Oncology) is organized to promote development of the field of neuro-oncology in the Asian region. The aims of the society are: • to establish and promote high standards for the treatment of patients with cancer affecting the nervous system • to elevate and sustain the education of all involved in neuro-oncology • to encourage mutual fellowship, goodwill, and scientific collaboration among physicians and scientists actively involved in the field of neuro-oncology. The organization has widened its coverage to become a multi-disciplinary group, by welcoming neurosurgeons, radiation oncologist, paediatric and adult oncologists, neurologists, neuropathologists, neuroradiologists, neuroscientists, neuropsychologists, neuropsychiatrists, and allied health professionals.
Asociación Peruana Vidas Sin Cáncer
In Spanish: "Nuestra organización nace en el 2012, impulsada por un grupo de profesionales oncólogos médicos para contribuir a revertir los altos índices de cáncer y los factores de riesgo que predisponen a estos en nuestro País, del mismo modo busca brindar el apoyo al paciente afectado con cáncer y a su familia, a través de una intervención multidisciplinaria e integral con el objetivo de mejorar su calidad de vida. Contamos con un equipo de profesionales y voluntarios comprometidos con el trabajo que realizamos, bajo los principios institucionales y comprometidos con el bienestar del paciente, la familia y la comunidad. Estamos desarrollando nuestra labor en cuatro líneas de acción: promoción de estilos de vida saludable, prevención de enfermedades oncológicas, investigación aplicada en cáncer y mejora de la calidad de vida del paciente afectado de cáncer. Nuestro trabajo busca incidir en autoridades y decisores a favor de los afectados por esta enfermedad, fomentar la autonomía del paciente para promover una sociedad inclusiva; facilitando y promoviendo el desarrollo a través de alianzas y redes."
ASPHO (American Society of Pediatric Hematology/Oncology)
Founded in 1981, the American Society of Pediatric Hematology/Oncology (ASPHO) currently has 2,000 members. ASPHO offers a forum for the exchange of ideas on issues of special interests and concern to people in the specialty, as well as a means for facilitating communication among members. ASPHO is the only professional organization dedicated solely to the professional development and interest of subspecialists in pediatric hematology/oncology. The Society works to actively advance programs and initiatives in professional education, scientific and clinical research, training, and practice issues. ASPHO represents pediatric hematologists/oncologists through active liaisons with numerous professional societies and alliances. Both ASPHO's conference and its journal, Pediatric Blood & Cancer, provide forums for presenting research to colleagues and peers. ASPHO welcomes members' involvement in volunteer activities such as standing committees, task forces, special interest groups, and contributions through member publications and other activities. You have the opportunity to make a difference in the profession through your personal involvement as an ASPHO member.
Association l’Avenir
Childhood-cancer advocacy organisation under international network.
Association On est là
In French: "L’association « On est là » soutient les adolescents et jeunes adultes touchés par un cancer grâce au pair-accompagnement. Sa force réside dans son réseau de bénévoles, tous anciens patients, qui mettent leur vécu au service du soutien moral. En organisant des groupes de parole, des espaces d’échange et des rencontres thématiques, l’association brise l’isolement lié à la maladie. Elle offre un cadre bienveillant où le partage d’expérience est un levier vers la reconstruction."
Astellas
Astellas is a global life sciences company committed to turning innovative science into VALUE for patients.
AstraZeneca
We are a global, science-led, patient-focused pharmaceutical business. We are committed to excellence in the research, development and commercialisation of prescription medicines. We aim to transform the lives of patients with improved outcomes and a better quality of life.
ASTRO (American Society for Radiation Oncology)
Founded in 1958, ASTRO’s mission is to advance the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving health care environment. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. These medical professionals, found at hospitals, cancer treatment centers and academic research facilities around the globe, make up the radiation therapy treatment teams that are critical in the fight against cancer. Together, these teams treat more than one million cancer patients each year. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research and advocacy. ASTRO provides members with the continuing medical education, health policy analysis, patient information resources and advocacy that they need to succeed in today’s ever-changing health care delivery system.
Auransa
We are a clinical stage, AI-native biopharma that mines massive data to advance novel therapies that raise the standard of cancer care.
Autolus Therapeutics
Autolus applies extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases and is building a fully integrated, next-generation CAR T company
Avistone Biotechnology
Avistone is a commercial-stage innovative biopharmaceutical company, and is committed to delivering high-quality innovative drugs to oncology patients worldwide, enabling them to achieve a better quality of life. For a decade, Avistone has been dedicated to first-in-class and best-in-class drugs, and has established a strong pipeline comprising multiple novel therapies, with several candidates in advanced global clinical development.
BACR (The British Association for Cancer Research)
The British Association for Cancer Research (BACR) is a professional membership association for all those working and studying in cancer research within the United Kingdom and beyond. We provide educational and training opportunities for all those involved in the cancer field, particularly the next generation of cancer research professionals. We organise scientific conferences and workshops, and offer meeting bursaries and fellowships, to enable our membership to attend cancer focused events around the world.